A role for the increase in circulating norepinephrine (NE) during intense exercise [IE; ≥80% maximum O2 uptake (V̇O2max)] in the marked increment in glucose rate of production (Ra) during IE is hypothesized. Seven fit male subjects (27 ± 2 yr old; body mass index, 23 ± 1 kg/m2; V̇O2max, 63 ± 5 mL/kg·min) underwent 40 min of postabsorptive moderate-intensity (53% V̇O2max) cycle ergometer exercise (126 ± 14 W), once without [control (CON)] and once with NE infusion (0.1 μg/kg·min) from 30–40 min (NE). With infusion, plasma NE reached 15.9 ± 1.0 nm (8-fold rest, 2-fold CON). Ra doubled to 4.40 ± 0.44 in CON, but rose to 7.55 ± 0.68 mg/kg·min with NE infusion (P = 0.003). Ra correlated strongly (r2 = 0.92, P < 0.02) with plasma NE during and immediately after infusion. With NE infusion, peak glucose uptake [rate of disappearance (Rd), 6.57 ± 0.59 vs. 4.53 ± 0.55 mg/kg·min, P< 0.02] and glucose metabolic clearance rate (P< 0.05) were higher than in CON. Glycemia rose minimally during the NE infusion but did not differ between groups at any time during exercise. Glucagon-to-insulin ratio increased minimally, and epinephrine increased approximately 2.5- to 3-fold at peak but did not differ between groups. Thus, NE infusion during moderate exercise led to increments in Ra and Rd in fit individuals, supporting a possible contributory role for the increase of plasma NE in IE. NE effects on Rd and metabolic clearance rate during exercise may differ from its effects at rest.

You do not currently have access to this article.